1-2 of 2
Mohamed Abou-el-Enein
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Cost-effectiveness of second-line lisocabtagene maraleucel in relapsed or refractory diffuse large B-cell lymphoma

Jee H. Choe, Tianzhou Yu, Jeremy S. Abramson, Mohamed Abou-el-Enein
Journal: Blood Advances
Blood Adv (2024) 8 (2): 484–496.
https://doi.org/10.1182/bloodadvances.2023011793
Published: 2024
Includes: Supplemental data
Journal Articles

CAR NK-92 cell–mediated depletion of residual TCR + cells for ultrapure allogeneic TCR-deleted CAR T-cell products

Jonas Kath, Weijie Du, Stefania Martini, Magdi Elsallab, Clemens Franke, Laura Hartmann, Vanessa Drosdek, Viktor Glaser, Maik Stein, Michael Schmueck-Henneresse, Petra Reinke, Hans-Dieter Volk, Mohamed Abou-el-Enein, Dimitrios L. Wagner
Journal: Blood Advances
Blood Adv (2023) 7 (15): 4124–4134.
https://doi.org/10.1182/bloodadvances.2022009397
Published: 2023
Includes: Supplemental data